| 000 | 01336nam a2200337 a 4500 | ||
|---|---|---|---|
| 005 | 20250913110146.0 | ||
| 008 | 981208s1985 xxua 00 eng b | ||
| 010 | _a85-004452 | ||
| 020 | _a0444904077 | ||
| 039 | 9 |
_a200606021158 _bjamil _c200606021157 _djamil _y08-18-1999 _zload |
|
| 060 |
_aWR220 _b.B131 1984 |
||
| 090 | _aWR220.B131 1984 9HUKM | ||
| 245 | 0 | 0 |
_aBactroban (mupirocin BRL 4910) : _bproceedings of an international symposium, Nassau, May 21-22, 1984 / _ceditors, R. L. Dobson ...[et al.] |
| 260 |
_aNew York : _bElsevier Science, _c1985 |
||
| 300 |
_a269 p. : _bill. ; _c25 cm. |
||
| 440 | 0 |
_aCurrent clinical practice series, _v16 |
|
| 650 | 0 |
_aSkin _xInfections _xChemotherapy _xEvaluation _vCongresses |
|
| 650 | 0 |
_aMupirocin _xTesting _vCongresses |
|
| 650 | 0 |
_aPyoderma _xChemotherapy _xEvaluation _vCongresses |
|
| 650 | 0 |
_aAntibiotics _xTherapeutic use _vCongresses |
|
| 650 | 0 |
_aSkin Diseases, Infectious _xdrug therapy _vCongresses |
|
| 650 | 0 |
_aFatty acids _xPharmacodynamics _vCongresses |
|
| 650 | 0 |
_aFatty acids _xTherapeutic use _vCongresses |
|
| 700 | 1 | _aDobson, Richard L | |
| 907 |
_a.b1017297x _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kWR220.B131 1984 9HUKM |
||
| 914 | _avtls000018142 | ||
| 991 | _aFakulti Perubatan | ||
| 998 |
_ah _b1999-05-08 _cm _da _feng _gxxu _y0 _z.b1017297x |
||
| 999 |
_c19319 _d19319 |
||